Latest Press

Cristcot Announces Positive Phase 3 Results for Novel Hydrocortisone Acetate Suppository Administered with the Sephure® Suppository Applicator for the Treatment of Ulcerative Colitis of the Rectum

Read

Rose Pharma Featured in The Obesity Bulletin - Rose Pharma Unveils Rose-010: First GLP-1 Therapy Focused on Weight Loss Maintenance

Read

ADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and the 18th International Conference on Malignant Lymphoma (ICML)

Read

Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape

Read

FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting Monoclonal Antibody, for the Treatment of Patients with Solid Tumors

Read

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

Read

Royalty Pharma

Transforming the funding of life sciences through collaborative capital, Royalty Pharma developed and is the leader in the pharmaceutical royalty business.

Royalty Pharma

RP

ADC Therapeutics

ADC Therapeutics is focused on the development of proprietary Antibody Drug Conjugates for the treatment of both solid and hematological cancers.

ADC Therapeutics

ADCT

Intra-Cellular Therapies

Intra-Cellular Therapies is a leading biopharmaceutical company founded by Nobel Prize winner: Paul Greengard...

Intra-Cellular Therapies

Scientia Ventures

Scientia

About

Portfolio

People

Podcasts

News

Portfolio

People

Podcasts

News

About

Portfolio

About

People

Podcasts

News

Portfolio

People

Podcasts

News

About

Scientia Ventures

knowledge is power

In short

Intelligent Investment in Healthcare

In Numbers

31

5

Latest Press

Cristcot Announces Positive Phase 3 Results for Novel Hydrocortisone Acetate Suppository Administered with the Sephure® Suppository Applicator for the Treatment of Ulcerative Colitis of the Rectum

Rose Pharma Featured in The Obesity Bulletin - Rose Pharma Unveils Rose-010: First GLP-1 Therapy Focused on Weight Loss Maintenance

ADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and the 18th International Conference on Malignant Lymphoma (ICML)

Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape

FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting Monoclonal Antibody, for the Treatment of Patients with Solid Tumors

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

Highlights

Royalty Pharma

RP

ADC Therapeutics

ADCT

Intra-Cellular Therapies

ICT

Intelligent Investment in Healthcare

SIGnUP

Scientia Ventures™

Intelligent Investment
in Healthcare

SIGn
UP